RxSight, Inc. (RXST) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Rxsight, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.593 Hello and thank you for standing by. My name is John and I will be your conference operator 00:00:03.593 -- 00:00:08.156 today. At this time, I would like to welcome everyone to the RxSight preliminary second 00:00:08.156 -- 00:00:12.759 quarter financial results and product pipeline updates following collaboration agreement. 00:00:12.759 -- 00:00:15.901 All lights have been placed in mute to prevent any background noise. 00:00:15.901 -- 00:00:19.183 After the speaker remarks, there will be a question and answer session. 00:00:19.183 -- 00:00:22.765 If you would like to ask a question during this time, simply press star followed by the 00:00:22.765 -- 00:00:26.648 number one on your telephone keypad. And to withdraw your question, simply press star 00:00:26.648 -- 00:00:31.636 one again. I would now like to turn the conference over to Oliver Moravcevic, VP of Investor 00:00:31.636 -- 00:00:34.617 Relations. Please go ahead. 00:00:34.718 -- 00:00:38.900 Thank you, Operator. With me on the call this morning is RxSight President and Chief 00:00:38.900 -- 00:00:44.023 Executive Officer, Dr. Ron Kurtz, and Chief Financial Officer, Mark Wilterly. 00:00:44.023 -- 00:00:48.965 Yesterday, RxSight released a pair of press releases, one reporting on a new collaboration 00:00:48.965 -- 00:00:53.388 agreement with Alcon, and the second reporting preliminary revenue results for the three 00:00:53.388 -- 00:00:56.338 months ending June 30, 2026. 00:00:56.338 -- 00:01:00.239 updated product pipeline, and revised folio guidance. 00:01:00.239 -- 00:01:05.800 Copies of both press releases and corresponding 8Ks are available on the company's website. 00:01:05.800 -- 00:01:09.561 Before we begin, I would like to inform you that comments and responses t...